Literature DB >> 16458664

Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats.

E Albert Reece1, Ying-King Wu, Zhiyong Zhao, Danny Dhanasekaran.   

Abstract

OBJECTIVE: Maternal diabetes causes developmental malformations in the embryo. Dietary supplementation with antioxidants can reduce the malformation rates in animal models. To investigate the molecular mechanisms underlying diabetes-induced embryonic abnormalities and dietary interventions, activity of mitogen-activated protein kinases and factors associated with apoptotic pathways were examined in the maternal diabetic rat model. STUDY
DESIGN: Diabetes was induced in pregnant rats using streptozotocin. In the yolk sacs of the embryos, activity of the extracellular signal-regulated kinases, Raf-1, and Akt was dramatically reduced in diabetic rats, whereas that of c-jun N-terminal kinases/stress-activated protein kinases was increased.
RESULTS: When the diabetic dams were fed with arachidonic acid, vitamin E, or a combination of arachidonic acid, vitamin E, and myoinositol, the changes in the expression of these kinases were reversed and correlated with the decreases in the rates of apoptosis and embryonic malformations.
CONCLUSION: These results suggest that mitogen-activated protein kinases are involved in diabetic embryopathy, and dietary supplementations can rescue the aberrant signaling pathways and reduce embryonic malformation rate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458664     DOI: 10.1016/j.ajog.2005.08.052

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  30 in total

Review 1.  Diabetes-induced birth defects: what do we know? What can we do?

Authors:  E Albert Reece
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

2.  Reduction in embryonic malformations and alleviation of endoplasmic reticulum stress by nitric oxide synthase inhibition in diabetic embryopathy.

Authors:  Zhiyong Zhao; Richard L Eckert; E Albert Reece
Journal:  Reprod Sci       Date:  2012-04-24       Impact factor: 3.060

3.  Resveratrol prevents impairment in activation of retinoic acid receptors and MAP kinases in the embryos of a rodent model of diabetic embryopathy.

Authors:  Chandra K Singh; Ambrish Kumar; Holly A LaVoie; Donald J DiPette; Ugra S Singh
Journal:  Reprod Sci       Date:  2012-04-24       Impact factor: 3.060

4.  SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy.

Authors:  Hongbo Weng; Xuezheng Li; E Albert Reece; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2012-02-22       Impact factor: 8.661

5.  The increased activity of a transcription factor inhibits autophagy in diabetic embryopathy.

Authors:  Cheng Xu; Xi Chen; E Albert Reece; Wenhui Lu; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2018-10-09       Impact factor: 8.661

6.  Hyperglycemia induces inducible nitric oxide synthase gene expression and consequent nitrosative stress via c-Jun N-terminal kinase activation.

Authors:  Peixin Yang; Yuanning Cao; Hua Li
Journal:  Am J Obstet Gynecol       Date:  2010-06-11       Impact factor: 8.661

7.  Maternal diet modulates the risk for neural tube defects in a mouse model of diabetic pregnancy.

Authors:  Claudia Kappen; Claudia Kruger; Jacalyn MacGowan; J Michael Salbaum
Journal:  Reprod Toxicol       Date:  2010-09-22       Impact factor: 3.143

Review 8.  Decoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling.

Authors:  Peixin Yang; E Albert Reece; Fang Wang; Rinat Gabbay-Benziv
Journal:  Am J Obstet Gynecol       Date:  2014-11-27       Impact factor: 8.661

Review 9.  New concepts in diabetic embryopathy.

Authors:  Zhiyong Zhao; E Albert Reece
Journal:  Clin Lab Med       Date:  2013-04-19       Impact factor: 1.935

10.  Maternal diabetes alters transcriptional programs in the developing embryo.

Authors:  Gabriela Pavlinkova; J Michael Salbaum; Claudia Kappen
Journal:  BMC Genomics       Date:  2009-06-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.